Johnson & Johnson Pauses Covid Vaccine Trial After Participant’s “Adverse Reaction”

The U.S. drugmaker started its 60,000-patient Phase 3 trial last month.
Source: Johnson & Johnson Pauses Covid Vaccine Trial After Participant’s “Adverse Reaction”